Hsp90β inhibitors prevent GLT-1 degradation but have no beneficial efficacy on absence epilepsy
暂无分享,去创建一个
[1] G. Brockmann,et al. Arch , 2020, Definitions.
[2] 김창호,et al. 35. , 1991, Maxime Planoudes, Lettres.
[3] J. Park,et al. Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model. , 2017, Anticancer research.
[4] Harry Lee,et al. Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling , 2017, International journal of oncology.
[5] Yan Shen,et al. Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy , 2017, The Journal of experimental medicine.
[6] T. Kjaer,et al. Detection of Paroxysms in Long-Term, Single-Channel EEG-Monitoring of Patients with Typical Absence Seizures , 2017, IEEE Journal of Translational Engineering in Health and Medicine.
[7] G. G. Regner,et al. Behavioral and genotoxic evaluation of rosmarinic and caffeic acid in acute seizure models induced by pentylenetetrazole and pilocarpine in mice , 2016, Naunyn-Schmiedeberg's Archives of Pharmacology.
[8] M. Carles,et al. A pharmacological basis of herbal medicines for epilepsy , 2015, Epilepsy & Behavior.
[9] L. Medina-Ceja,et al. Effect of sparteine on status epilepticus induced in rats by pentylenetetrazole, pilocarpine and kainic acid , 2015, Brain Research.
[10] M. Glicksman,et al. Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer’s disease , 2015, The Journal of experimental medicine.
[11] H. Sontheimer,et al. Reactive Astrogliosis Causes the Development of Spontaneous Seizures , 2015, The Journal of Neuroscience.
[12] L. Héja,et al. Astrocytic target mechanisms in epilepsy. , 2014, Current medicinal chemistry.
[13] R. Vandenberg,et al. Mechanisms of glutamate transport. , 2013, Physiological reviews.
[14] Jeffrey R Tenney,et al. The Current State of Absence Epilepsy: Can We Have Your Attention? , 2013, Epilepsy currents.
[15] O. Yalçin. Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies , 2012, Seizure.
[16] Yi-Song Wang,et al. STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer. , 2010, Current opinion in investigational drugs.
[17] D. Hirtz,et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. , 2010, The New England journal of medicine.
[18] P. Ossenblok,et al. Onset and propagation of spike and slow wave discharges in human absence epilepsy: A MEG study , 2009, Epilepsia.
[19] C. Panayiotopoulos,et al. Typical absence seizures and related epileptic syndromes: Assessment of current state and directions for future research , 2008, Epilepsia.
[20] Gregory L. Holmes,et al. Animal model studies application to human patients , 2007, Neurology.
[21] I. Scheffer,et al. Electroclinical features of absence seizures in childhood absence epilepsy , 2006, Neurology.
[22] S. Lindquist,et al. HSP90 and the chaperoning of cancer , 2005, Nature Reviews Cancer.
[23] G. Holmes,et al. Lamictal (Lamotrigine) Monotherapy for Typical Absence Seizures in Children , 1999, Epilepsia.
[24] Dreifuss Fe,et al. Automatisms associated with the absence of petit mal epilepsy. , 1969 .
[25] D. Daly. Reflections on the Concept of Petit Mai , 1968, Epilepsia.
[26] W. Lennox. The heredity of epilepsy as told by relatives and twins. , 1951, Journal of the American Medical Association.